Journal of Medical Economics
Volume 26, 2023 - Issue 1
Open access
2,710
Views
0
CrossRef citations to date
0
Altmetric
Cardiovascular
Comparative evaluation of costs and healthcare resource utilization of oral selexipag versus inhaled treprostinil or oral treprostinil in patients with pulmonary arterial hypertension
Eros Papademetrioua Putnam PHMR, Value Pricing and Access, New York, NY, USA;Correspondence[email protected]
https://orcid.org/0000-0002-9932-566XView further author information
, https://orcid.org/0000-0002-9932-566XView further author information
Xing Liua Putnam PHMR, Value Pricing and Access, New York, NY, USA;View further author information
, Amélie Beaudetb Actelion Pharmaceuticals Ltd, Global Market Access, Allschwil, SwitzerlandView further author information
, Yuen Tsangc Janssen Scientific Affairs, LLC, Real World Value & Evidence, Titusville, NJ, USAView further author information
, Ravi Potluria Putnam PHMR, Value Pricing and Access, New York, NY, USA;View further author information
& Sumeet Panjabic Janssen Scientific Affairs, LLC, Real World Value & Evidence, Titusville, NJ, USAView further author information
Pages 644-655
|
Received 02 Mar 2023, Accepted 17 Apr 2023, Published online: 07 May 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.